|Bid||1.9100 x 1200|
|Ask||1.9200 x 2200|
|Day's Range||1.8950 - 1.9300|
|52 Week Range||1.6500 - 3.0600|
|Beta (5Y Monthly)||-0.82|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
AIM ImmunoTech Inc. (NYSEMKT:AIM) last week reported its latest third-quarter results, which makes it a good time for...
This article will reflect on the compensation paid to Thomas Equels who has served as CEO of AIM ImmunoTech Inc...